{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:45:39Z","timestamp":1778949939342,"version":"3.51.4"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"JSPS KAKENHI","award":["19H03865"],"award-info":[{"award-number":["19H03865"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Testing with fingertip blood sampling, including HbA1c testing, has been available in community pharmacies in Japan since 2014. In 2016, the Mihara Pharmacy Association in Hiroshima Prefecture, in collaboration with the Mihara municipal government, developed a community programme that utilized the walk-in HbA1c test that could be offered by participating community pharmacies. The aim of this study was to assess whether the new programme could detect undiagnosed DM in the community and to compare groups who had and had not accessed the SHCG programme among SHCG eligible participants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>The programme includes pharmacist advice following participants conducted Hba1c testing in the pharmacy, and completing a questionnaire to collect self-reported personal data including lifestyle, demography, height, weight, and blood pressure. All those accessing the programme were included. We analysed data from fiscal years 2016 to 2018, obtained retrospectively from the questionnaires.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>The participants aged 40\u201374 years who were the target of a national health check programme represented 73.7% of the 1933 total unique participants. Approximately 40% of these participants did not undergo routine checkups, 23.8% had HbA1c scores \u22655.6%, and 2.7% had HbA1c scores \u22656.5%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The walk-in HbA1c community testing programme provided an opportunity to test the diabetes mellitus risk of residents, especially those who have missed their routine checkups. If the community programme were adopted widely, more undiagnosed populations at risk for diabetes mellitus could be detected in the early stages and the use of community resources such as pharmacists and pharmacies would be utilized.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ijpp\/riaf005","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T12:52:26Z","timestamp":1738155146000},"page":"188-196","source":"Crossref","is-referenced-by-count":2,"title":["Community-based HbA1c testing programme for early detection of undiagnosed diabetes in community pharmacy"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9986-6159","authenticated-orcid":false,"given":"Aiko","family":"Shono","sequence":"first","affiliation":[{"name":"Laboratory of Public Health, Showa Pharmaceutical University , Machida, Tokyo 194-8543 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aki","family":"Morihiro","sequence":"additional","affiliation":[{"name":"Mihara Pharmaceutical Association, Center Pharmacy , Mihara, Hiroshima 723-0051 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobue","family":"Harada","sequence":"additional","affiliation":[{"name":"Mihara Pharmaceutical Association, Center Pharmacy , Mihara, Hiroshima 723-0051 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xerxes","family":"Seposo","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Graduate School of Medicine, Hokkaido University , Kita-ku, Sapporo Hokkaido 060-8638 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5704-343X","authenticated-orcid":false,"given":"Wataru","family":"Mimura","sequence":"additional","affiliation":[{"name":"Section of Clinical Epidemiology, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine , Shinjuku-ku, Tokyo 162-8655 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-ling","family":"Hoshi","sequence":"additional","affiliation":[{"name":"Department of Health Care Policy and Health Economics, Institute of Medicine, University of Tsukuba , Tsukuba, Ibaraki 3058577 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1823-1865","authenticated-orcid":false,"given":"Naoya","family":"Yahagi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, School of Medicine, Jichi Medical University , Shimotsuke-shi, Tochigi 329-0498 ,","place":["Japan"]},{"name":"Nutrigenomics Research Group, Institute of Medicine, University of Tsukuba , Tsukuba, Ibaraki 305-8575 ,","place":["Japan"]},{"name":"Revolution of Access to Diabetes Diagnosis (RADD) Project , Tsukuba, Ibaraki 305-8575 ,","place":["Japan"]},{"name":"The Cooperation Council for Specimen Measurement Offices , Chiyoda-ku, Tokyo 101-0032 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiko","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Laboratory of Social Pharmacy and Regulatory Science, Showa Pharmaceutical University , Machida, Tokyo 194-8543 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Health Care Policy and Health Economics, Institute of Medicine, University of Tsukuba , Tsukuba, Ibaraki 3058577 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"2025041522370241300_CIT0001","doi-asserted-by":"publisher","first-page":"l969","DOI":"10.1136\/bmj.l969","article-title":"Contribution of specific diseases and injuries to changes in health adjusted life expectancy in 187 countries from 1990 to 2013: retrospective observational study","volume":"364","author":"Chen","year":"2019","journal-title":"BMJ"},{"key":"2025041522370241300_CIT0002","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/S2214-109X(17)30058-X","article-title":"Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: a systematic review","volume":"5","author":"Allen","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2025041522370241300_CIT0003","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","article-title":"Type 2 diabetes","volume":"400","author":"Ahmad","year":"2022","journal-title":"Lancet"},{"key":"2025041522370241300_CIT0004","author":"World Health Organization"},{"key":"2025041522370241300_CIT0005","author":"World Health Organization"},{"key":"2025041522370241300_CIT0006","author":"The NHS website for England"},{"key":"2025041522370241300_CIT0007","doi-asserted-by":"publisher","first-page":"Art. No.: CD009009","DOI":"10.1002\/14651858.CD009009.pub3","article-title":"General health checks in adults for reducing morbidity and mortality from disease","author":"Krogsb\u00f8ll","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2025041522370241300_CIT0008","doi-asserted-by":"publisher","first-page":"e052832","DOI":"10.1136\/bmjopen-2021-052832","article-title":"NHS Health Check programme: a rapid review update","volume":"12","author":"Tanner","year":"2022","journal-title":"BMJ Open"},{"key":"2025041522370241300_CIT0009","author":"Ministry of Health, Labour and Welfare"},{"key":"2025041522370241300_CIT0010","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.2169\/internalmedicine.4975-20","article-title":"Impact of metabolic syndrome on the mortality rate among participants in a specific health check and guidance program in Japan","volume":"59","author":"Iseki","year":"2020","journal-title":"Intern Med"},{"key":"2025041522370241300_CIT0011","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1536\/ihj.49.193","article-title":"The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome","volume":"49","author":"Kohro","year":"2008","journal-title":"Int Heart J"},{"key":"2025041522370241300_CIT0012","author":"Ministry of Health, Labour and Welfare"},{"key":"2025041522370241300_CIT0013","author":"Japan Pharmaceutical Association"},{"key":"2025041522370241300_CIT0014","author":"Yubisaki self sokuteishitsu Navi"},{"key":"2025041522370241300_CIT0015","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/eurpub\/cky009","article-title":"Detecting persons at risk for diabetes mellitus type 2 using FINDRISC: results from a community pharmacy-based study","volume":"28","author":"Milovanovic","year":"2018","journal-title":"Eur J Public Health"},{"key":"2025041522370241300_CIT0016","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/1471-2458-14-487","article-title":"Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study","volume":"14","author":"Via-Sosa","year":"2014","journal-title":"BMC Public Health"},{"key":"2025041522370241300_CIT0017","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11096-006-9034-6","article-title":"Sequential screening for diabetes\u2014evaluation of a campaign in Swiss community pharmacies","volume":"28","author":"Hersberger","year":"2006","journal-title":"Pharm World Sci"},{"key":"2025041522370241300_CIT0018","doi-asserted-by":"publisher","first-page":"e0229842","DOI":"10.1371\/journal.pone.0229842","article-title":"Opportunistic screening for type 2 diabetes in community pharmacies. Results from a region-wide experience in Italy","volume":"15","author":"Gnavi","year":"2020","journal-title":"PLoS One"},{"key":"2025041522370241300_CIT0019","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ijpp\/riad055","article-title":"Diabetes risk assessments and HbA1c-measurements in community pharmacies","volume":"31","author":"Ris\u00f8y","year":"2023","journal-title":"Int J Pharm Pract"},{"key":"2025041522370241300_CIT0020","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.sapharm.2020.03.014","article-title":"Budget impact analysis reveals walk-in fingertip HbA1c testing in community pharmacies could provide a significant long-term reduction in public expenditure","volume":"17","author":"Shono","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"2025041522370241300_CIT0021","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2337\/dc17-1307","article-title":"Cost-effectiveness of a new opportunistic screening strategy for walk-in fingertip HbA1c testing at community pharmacies in Japan","volume":"41","author":"Shono","year":"2018","journal-title":"Diabetes Care"},{"key":"2025041522370241300_CIT0022","author":"Mihara-shi Kokumin kenkou hoken deta health keikaku (dai 2ki keikaku)","journal-title":"Mihara city National Health Insurance Data Health Plan (ver.2)"},{"key":"2025041522370241300_CIT0023","author":"Ministry of Health, Labour and Welfare"},{"key":"2025041522370241300_CIT0024","author":"Hirosima-ken Kenkouhukushi-kyoku Yakumu-ka","journal-title":"Heisei 27 nenndo Yakumu-ka jigyou gaiyou. (An overview of the project, ver.2014)"},{"key":"2025041522370241300_CIT0025","author":"World Health Organization","journal-title":"A healthy lifestyle - WHO recommendations"},{"key":"2025041522370241300_CIT0026","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ecl.2021.05.002","article-title":"Screening for diabetes and prediabetes","volume":"50","author":"Duan","year":"2021","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2025041522370241300_CIT0027","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/pubmed\/fdz051","article-title":"Factors associated with undiagnosed type II diabetes mellitus, undiagnosed impaired fasting glucose and these patients\u2019 quality of life in Lebanon","volume":"42","author":"Hallit","year":"2020","journal-title":"J Public Health (Oxf)"},{"key":"2025041522370241300_CIT0028","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"2025041522370241300_CIT0029","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/1471-2458-10-444","article-title":"Community pharmacists\u2019 involvement in smoking cessation: familiarity and implementation of the National smoking cessation guideline in Finland","volume":"10","author":"Kurko","year":"2010","journal-title":"BMC Public Health"},{"key":"2025041522370241300_CIT0030","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s11096-019-00852-0","article-title":"Balancing traditional activities and cognitive pharmaceutical services by community pharmacists: a work sampling study","volume":"41","author":"van de Pol","year":"2019","journal-title":"Int J Clin Pharm"},{"key":"2025041522370241300_CIT0031","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.18549\/PharmPract.2021.1.2248","article-title":"Primary healthcare policy and vision for community pharmacy and pharmacists in Germany","volume":"19","author":"Eickhoff","year":"2021","journal-title":"Pharm Pract"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/33\/2\/188\/61860545\/riaf005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/33\/2\/188\/61860545\/riaf005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T02:37:24Z","timestamp":1744771044000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/33\/2\/188\/8010406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,12]]},"published-print":{"date-parts":[[2025,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ijpp\/riaf005","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,2,12]]}}}